Earnings History Data for Fate Therapeutics, Inc. (FATE) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Fate Therapeutics, Inc.

Fate Therapeutics, Inc. is a biopharmaceutical company. The company focused on the discovery and development of adult stem cell modulators to treat hematologic malignancies, lysosomal storage disorders and muscular dystrophies. Fate Therapeutics, Inc. is headquartered in San Diego, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
12-11-2024	AH		FATE	Fate Therapeutics	276.00	-0.40	-0.42	0.00	Fate Therapeutics GAAP EPS of -$0.40 beats by $0.01, revenue of $3.07M beats by $1.63M [11/12/2024 6:18 PM]	2.16	-0.22 (-9.24%)	2.43	0.05 (2.10%)	1.94 - 8.83	1,520,385	1,580,000	1,099
Fate Therapeutics GAAP EPS of -$0.40 beats by $0.01, revenue of $3.07M beats by $1.63M [11/12/2024 6:18 PM] Fate Therapeutics: Q3 Earnings Snapshot [2024-11-12 04:18PM] Fate Therapeutics Reports Third Quarter 2024 Financial Results and Business Updates [2024-11-12 04:01PM] Fate Therapeutics (FATE) Reports Q3 Loss, Tops Revenue Estimates [Nov-12-24 05:20PM]
09-05-2024	AH		FATE	Fate Therapeutics, Inc.	385.04	-0.47	-0.47	-0.19	Fate Therapeutics GAAP EPS of -$0.47 in-line, revenue of $1.93M beats by $0.67M [5/9/2024 4:04 PM]	4.11	0.21 (5.38%)	3.86	-0.04 (-1.03%)	1.63 - 8.83	5,785,111	3,130,000	2,402
Fate Therapeutics GAAP EPS of -$0.47 in-line, revenue of $1.93M beats by $0.67M [5/9/2024 4:04 PM]
26-02-2024	AH		FATE	Fate Therapeutics, Inc.	678.38	-0.45	-0.57	-0.58	Fate Therapeutics GAAP EPS of -$0.45 beats by $0.08, revenue of $1.7M beats by $0.17M [2/26/2024 4:04 PM]	7.51	0.56 (8.13%)	7.49	0.54 (7.77%)	1.63 - 8.63	3,744,424	2,240,000	10,092
Fate Therapeutics GAAP EPS of -$0.45 beats by $0.08, revenue of $1.7M beats by $0.17M [2/26/2024 4:04 PM]
08-11-2023	AH		FATE	Fate Therapeutics, Inc.	247.39	-0.46	-0.59	-0.86	Fate Therapeutics GAAP EPS of -$0.46 beats by $0.12, revenue of $1.94M beats by $1.04M [11/8/2023 4:02 PM]	2.14	-0.19 (-8.15%)	2.45	0.12 (5.15%)	1.63 - 23.96	4,089,203	1,860,000	6,978
Fate Therapeutics GAAP EPS of -$0.46 beats by $0.12, revenue of $1.94M beats by $1.04M [11/8/2023 4:02 PM] Fate Therapeutics files $300M mixed securities shelf [11/9/2023 9:00 AM]
08-08-2023	AH		FATE	Fate Therapeutics, Inc.	366.97	-0.54	-0.58	-0.79	Fate Therapeutics GAAP EPS of -$0.54 beats by $0.06, revenue of $0.93M misses by $4.81M [8/8/2023 4:16 PM]	3.38	-0.15 (-4.11%)	3.53	0.0 (0.00%)	3.34 - 36.75	2,346,227	1,830,000	26,236
Fate Therapeutics GAAP EPS of -$0.54 beats by $0.06, revenue of $0.93M misses by $4.81M [8/8/2023 4:16 PM]
03-05-2023	AH	4:00 PM ET (May 3)	FATE	Fate Therapeutics, Inc.	624.61	-0.19	-0.55	-0.68	Fate Therapeutics GAAP EPS of -$0.19 beats by $0.47, revenue of $58.98M beats by $25.45M [5/3/2023 4:05 PM]	6.16	-0.17 (-2.61%)	6.02	-0.30 (-4.75%)	4.02 - 37.13	2,243,143	2,250,000	646
Fate Therapeutics GAAP EPS of -$0.19 beats by $0.47, revenue of $58.98M beats by $25.45M [5/3/2023 4:05 PM]
28-02-2023	AH	4:00 PM ET (Feb 28)	FATE	Fate Therapeutics, Inc.	613.15	-0.58	-0.86	-0.72	Fate Therapeutics GAAP EPS of -$0.58 beats by $0.29, revenue of $44.34M beats by $25.93M [2/28/2023 4:05 PM]	6.14	0.02 (0.41%)	6.22	0.10 (1.63%)	4.02 - 43.12	2,401,515	2,620,000	2,284
Fate Therapeutics GAAP EPS of -$0.58 beats by $0.29, revenue of $44.34M beats by $25.93M [2/28/2023 4:05 PM]
03-11-2022	AH	4:00 PM ET (Nov 3)	FATE	Fate Therapeutics, Inc.	2,040	-0.86	-0.93	-0.57	Fate Therapeutics GAAP EPS of -$0.86 beats by $0.04, revenue of $14.98M misses by $0.51M [11/3/2022 4:04 PM]	19.77	0.32 (1.62%)	20.06	0.61 (3.14%)	17.10 - 66.56	1,780,678	1,320,000	18,486
Fate Therapeutics GAAP EPS of -$0.86 beats by $0.04, revenue of $14.98M misses by $0.51M [11/3/2022 4:04 PM] Fate Therapeutics to Present Clinical and Preclinical Data for iPSC Product Platform at the 2022 ASH Annual Meeting [Nov-03-22 09:00AM] Fate Therapeutics (FATE) Reports Q3 Loss, Lags Revenue Estimates [Nov-03-22 05:35PM] Fate Therapeutics Reports Third Quarter 2022 Financial Results and Highlights Operational Progress [Nov-03-22 04:01PM]
03-08-2022	AH	4:00 PM ET (Aug 3)	FATE	Fate Therapeutics, Inc.	3,000	-0.79	-0.86	-0.58	Fate Therapeutics GAAP EPS of -$0.79 beats by $0.04, revenue of $18.55M beats by $5.99M [8/3/2022 4:45 PM]	32.48	-0.33 (-1.02%)	3.92	-0.40 (-9.26%)	17.10 - 97.43	1,876,615	1,010,000	51,552
Fate Therapeutics GAAP EPS of -$0.79 beats by $0.04, revenue of $18.55M beats by $5.99M [8/3/2022 4:45 PM] Fate Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Operational Progress [Aug-03-22 04:01PM]
04-05-2022	AH	4:00 PM ET (May 4)	FATE	Fate Therapeutics	2,758	-0.68	-0.78	0.00	Fate Therapeutics GAAP EPS of -$0.68 beats by $0.11, revenue of $18.4M beats by $9.39M [5/4/2022 4:05 PM]	27.04	-3.65 (-11.89%)	29.50	-1.19 (-3.88%)	26.82 - 97.43	1,738,730	1,290,000	18,853
Fate Therapeutics GAAP EPS of -$0.68 beats by $0.11, revenue of $18.4M beats by $9.39M [5/4/2022 4:05 PM] Fate Therapeutics Reports First Quarter 2022 Financial Results and Highlights Operational Progress [May-04-22 04:01PM] Fate Therapeutics (FATE) Reports Q1 Loss, Tops Revenue Estimates [May-04-22 05:15PM] FATE's Loss Narrower Than Expected in Q1, Pipeline in Focus [May-05-22 10:18AM]
28-02-2022	AH	4:00 PM ET (Feb 28)	FATE	Fate Therapeutics, Inc.	3,240	-0.72	-0.68	-0.38	Fate Therapeutics GAAP EPS of -$0.72 misses by $0.04, revenue of $17.07M beats by $5.52M [2/28/2022 4:01 PM]	34.30	-0.25 (-0.72%)	34.55	0.0 (0.00%)	30.14 - 98.86	1,490,165	1,440,000	512,969
Fate Therapeutics GAAP EPS of -$0.72 misses by $0.04, revenue of $17.07M beats by $5.52M [2/28/2022 4:01 PM] Fate Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Operational Progress [Feb-28-22 04:01PM] Fate Therapeutics (FATE) Reports Q4 Loss, Tops Revenue Estimates [Feb-28-22 05:45PM] FATE's Loss Wider Than Expected in Q4, Pipeline in Focus [Mar-01-22 11:59AM]
04-11-2021	AH	4:00 PM ET (Nov 4)	FATE	Fate Therapeutics, Inc.	5,500	-0.57	-0.58	-0.36	Fate Therapeutics EPS beats by $0.13, beats on revenue [11/4/2021 4:06 PM]	61.38	1.74 (2.91%)	59.47	-0.18 (-0.30%)	47.20 - 121.16	832,641	1,070,000	937
Fate Therapeutics EPS beats by $0.13, beats on revenue [11/4/2021 4:06 PM] Fate Therapeutics Announces Eight Presentations at the 2021 ASH Annual Meeting [Nov-04-21 09:01AM] Fate Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Operational Progress [Nov-04-21 04:01PM] Fate Therapeutics (FATE) Reports Q3 Loss, Tops Revenue Estimates [Nov-04-21 05:15PM] FATE's Q3 Loss Narrower Than Expected, Pipeline in Focus [Nov-05-21 09:24AM]
04-08-2021	AH	4:00 PM ET (Aug 4)	FATE	Fate Therapeutics, Inc.	7,790	-0.58	-0.52	-0.35	Fate Therapeutics EPS misses by $0.05, beats on revenue [8/4/2021 4:06 PM]	95.65	9.92 (11.57%)	85.70	-0.03 (-0.03%)	29.37 - 121.16	1,079,142	740,000	180
Fate Therapeutics EPS misses by $0.05, beats on revenue [8/4/2021 4:06 PM] Fate Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Operational Progress [Aug-04-21 04:01PM] Fate Therapeutics (FATE) Reports Q2 Loss, Tops Revenue Estimates [Aug-04-21 05:55PM] FATE Reports Wider-Than-Expected Q2 Loss, Beats on Revenues [Aug-05-21 11:41AM]
05-05-2021	AH	4:00 PM ET (May 5)	FATE	Fate Therapeutics, Inc.	8,210	-0.48	-0.42	-0.44	Fate Therapeutics EPS misses by $0.05, beats on revenue [5/5/2021 4:04 PM]	76.55	-1.18 (-1.52%)	76.55	0.0 (0.00%)	25.60 - 121.16	1,855,622	870,000	6,536
Fate Therapeutics, Inc. to Host Earnings Call [May-05-21 03:15PM] Fate Therapeutics Reports First Quarter 2021 Financial Results and Highlights Operational Progress [May-05-21 04:01PM] Fate Therapeutics (FATE) Reports Q1 Loss, Tops Revenue Estimates [May-05-21 05:15PM] Fate Therapeutics Inc (FATE) Q1 2021 Earnings Call Transcript [May-06-21 11:01AM] FATE Reports Wider-Than-Expected Q1 Loss, Beats on Revenues [May-06-21 01:29PM]
24-02-2021	AH	4:00 PM ET (Feb 24)	FATE	Fate Therapeutics, Inc.	10,180	-0.38	-0.38	-0.37	Fate Therapeutics EPS misses by $0.22, beats on revenue [2/24/2021 4:05 PM]	86.22	-9.05 (-9.50%)	99.91	4.64 (4.87%)	16.75 - 121.16	1,143,872	960,097	3,845
Fate Therapeutics EPS misses by $0.22, beats on revenue [2/24/2021 4:05 PM] Fate Therapeutics: Q4 Earnings Insights [Feb-24-21 04:55PM]
05-11-2020	AH	4:00 PM ET (Nov 5)	FATE	Fate Therapeutics, Inc.	3,960	-0.36	-0.29	-0.40	Fate Therapeutics EPS misses by $0.36, beats on revenue [11/5/2020 4:40 PM]	48.15	-1.77 (-3.55%)	50.25	0.33 (0.66%)	12.59 - 51.45	479,132	624,716	1,641

05-08-2020	AH	4:00 PM ET (Aug 5)	FATE	Fate Therapeutics, Inc.	2,710	-0.35	-0.20	-0.36	Fate Therapeutics EPS misses by $0.10, misses on revenue [8/5/2020 4:02 PM]	33.68	0.84 (2.57%)	32.00	-0.84 (-2.56%)	12.59 - 38.52	511,072	565,345	230